aTYR PHARMA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
aTYR PHARMA INC (ATYR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 479.15 thousand shares for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-10.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2016-08-10
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2016-06-30 was 164.70K shares.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2016-03-31 was 314.45K shares.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2015-12-31 was -6.53K shares.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2015-09-30 was 410.72K shares.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2015 was 406.97K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2016-06-30 | 164.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | 479.15K shares 10-Q · filed 2016-08-10 | 472.62K shares derived: sum of 3 quarters · filed 2016-08-10 | 883.34K shares derived: sum of 4 quarters · filed 2016-08-10 |
| 2016-03-31 | 314.45K shares 10-Q · filed 2016-05-11 | 307.92K shares derived: sum of 2 quarters · filed 2016-05-11 | 718.64K shares derived: sum of 3 quarters · filed 2016-05-11 | |
| 2015-12-31 | -6.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 404.19K shares derived: sum of 2 quarters · filed 2016-03-30 | 406.97K shares 10-K · filed 2016-03-30 | |
| 2015-09-30 | 410.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 413.49K shares 10-Q · filed 2015-11-10 | ||
| 2015-06-30 | 2.77K shares 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |